Investing Profile

Dorothy Margolskee

VCInvestor
Senior Advisor at Prospect Venture Partners
Photo of Dorothy Margolskee, Prospect Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
898 CONNECTIONS
Karlshochschule International University Network
533 CONNECTIONS
Karlshochschule International University Network
533 CONNECTIONS
Karlshochschule International University Network
533 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
CompanyStageDateRound SizeTotal Raised
Affinivax
Series CJan 2021$230M
$350M
Co-investors: Andrew Hack (Bain Capital Ventures)
Fellow, Pulmonary Medicine Focus ConsultingPresent
Fellow, Pulmonary Medicine Karlshochschule International UniversityPresent
Associate Director, Clinical Pharmacology Merck Research LabsPresent
Director, Clinical Pharmacology Merck Research LabsPresent
Executive Director, Project Planning and Development Merck Research LabsPresent
Vice President, Project and Vaccine Integration Merck Research LabsPresent
Managing Director Focus ConsultingPresent
Managing Director Karlshochschule International UniversityPresent
Founder and Principal Focus ConsultingPresent
Founder and Principal Karlshochschule International UniversityPresent
Resident, Internal Medicine Johns Hopkins HospitalPresent
Fellow, Pulmonary Medicine Financial Services, Financial Technology, and Business ServicesPresent
Senior Vice President, Project & Vaccine Integration Merck Research LabsPresent
Managing Director Prospect Venture PartnersPresent
Senior Advisor Prospect Venture PartnersPresent
Managing Director Financial Services, Financial Technology, and Business ServicesPresent
Founder and Principal Financial Services, Financial Technology, and Business ServicesPresent
Harvard University B.A. Biochemistry and Molecular Biology
The Johns Hopkins University School of Medicine MD Internal Medicine
Sign in with Google →
Sign in with Google →